Business
Chinook's subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany
Chinook's subsidiary, AMP Alternative Medical Products, enters into a memorandum of unders...
About this update from Greenrise Global Brands Inc
[{"type":"text","content":"\n\n\n\nChinook's subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nERFURT, Germany and EDMONTON, Feb. 7, 2019\n\n\n\n ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ - AMP Alternative Medical Products GmbH (\"AMP\"), a subsidiary of Chinook Tyee Industry Limited (\"Chinook\") (TSXV: XCX), has entered into a non-binding Memorandum of Understanding Production Supply Agreement (\"MOU\") with Pure Life Cannabis Corporation (\"PLCC\"), a late-stage Health Canada applicant to become a licensed producer of cannabis (\"LP\") based in Edmonton, Alberta.  \nPLCC is in the process of building a 27,280 square foot Phase 1 facility, which it anticipates can produce approximately 2,000 kilograms of EU-GMP cannabis flower annually and 8,000 kilograms of cannabis flower product for the Canadian marketplace.    \nThe non-binding MOU covers the purchase of up to 1,200 kilograms of cannabis flower annually in the first year of production, increasing thereafter when PLCC proceeds with Phase 2 and 3 expansion plans. Pursuant to the non-binding MOU, PLCC is in the process of conducting an EU-GMP gap analysis with AMP's German pharmaceutical consultants.  Upon completion of the PLCC Phase 1 facility, AMP's German pharmaceutical consultants intend to conduct an audit of the facility. If EU-GMP standards are met, AMP and PLCC intend to enter into a Definitive Supply Agreement outlining pricing and monthly supply volumes, which agreement will also contain a number of conditions in order to complete the transactions contemplated herein. AMP intends to arrange for final EU-GMP certification by German State Officials and apply for the required import licenses for medical cannabis to Germany. \nAccording to Mr. Alex Blodgett, CEO of Chinook, \"We are delighted to have Pure Life on board as a medical cannabis supply partner especially as Germany is predicted to pass the one million patient mile...